GS vs MS: Which Is the Better Buy?

Side-by-side comparison of The Goldman Sachs Group, Inc. and Morgan Stanley β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-04-29.
The Goldman Sachs Group, Inc. Β· Financial Services
$926.55
-45.0% upside to fair value
Grade D
VS
Morgan Stanley Β· Financial Services
$189.30
+45.0% upside to fair value
Grade C High Quality
QuantHub Verdict
MS has more upside to fair value (+45.0%). GS trades at a lower forward P/E (15.6x). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric GS MS
Current Price $926.55 $189.30
Fair Value Estimate $509.60 $274.49
Upside to Fair Value -45.0% +45.0%
Market Cap $275.0B $300.6B
Forward P/E 15.6x 16.4x
EV / EBITDA 30.6x 24.4x
Price / Sales 2.5x 2.5x
Price / FCF -5.8x -16.8x
Revenue Growth YoY -45.4% +18.8%
Gross Margin 55.5% 58.0%
Operating Margin 20.5% 19.5%
Return on Equity 14.6% 16.7%
Dividend Yield 0% 0%
FCF Yield β€” β€”
Analyst Consensus Hold Hold
Investment Thesis
GS β€” The Goldman Sachs Group, Inc.
The Goldman Sachs Group, Inc. operates as a leading global financial services firm specializing in investment banking, securities, investment management, and consumer banking. The company benefits from a high-quality business model characterized by strong brand recognition, deep client relationships, and a history of stable leadership. However, the stock is currently significantly overvalued, tra…
MS β€” Morgan Stanley
Morgan Stanley is a leading global financial services firm operating in Institutional Securities, Wealth Management, and Investment Management. The company benefits from a durable competitive moat supported by its systemically important status, diversified revenue streams, and strong management with a 36-year veteran CEO. Despite solid fundamentals including 14.2% revenue growth in 2025 and 16.7%…
Accumulation Zones
Metric GS MS
Zone Low $382.20 $205.87
Zone High $433.16 $233.32
In Buy Zone? No Yes
← GS Research    MS Research β†’    All Research